Quick Answer
Inhibrx Biosciences, Inc. reported Total Assets of $146.48 million for the year ending 2025.
- Inhibrx Biosciences, Inc. showed a decrease of -19.0% in Total Assets from 2024 to 2025.
- This data is from Inhibrx Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2024: $258.42 million | Q3 2024: $222.56 million | Q1 2025: $242.64 million | Q2 2025: $212.12 million | Q3 2025: $177.47 million.
- Over the full 3 years of available data (2023 to 2025), Inhibrx Biosciences, Inc.'s Total Assets has declined by 52.4%.
- Historical annual values: Fiscal year 2025: $146.48 million | Fiscal year 2024: $180.77 million | Fiscal year 2023: $307.89 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: